Cabaletta Bio (CABA) Shares Issued (2018 - 2026)
Cabaletta Bio (CABA) posted quarterly Shares Issued of $13.8 million for Q4 2025, up 23.19% year-over-year from $11.2 million in Q4 2024, and up 1.59% quarter-over-quarter from $13.6 million in Q3 2025.
Cabaletta Bio (CABA) Shares Issued (2018 - 2026) Analysis & Trends
Cabaletta Bio's Shares Issued history runs 8 years deep, the most recent figure standing at $13.8 million for Q4 2025.
- In Q4 2025, Shares Issued rose 23.19% year-over-year to $13.8 million; the TTM figure through Dec 2025 stood at $13.8 million (up 23.19% YoY), while the FY2025 annual figure was $13.8 million, up 23.19% from the prior year.
- Shares Issued for Q4 2025 stood at $13.8 million, up from $13.6 million in the prior quarter.
- The five-year high for Shares Issued was $13.8 million in Q4 2025, with the low at $1.1 million in Q1 2022.
- The 5-year median for Shares Issued is $5.6 million (2022), against an average of $6.3 million.
- The sharpest annual moves came in 2021 and 2023: Shares Issued plunged 44.48% in 2021, then soared 601.42% in 2023.
- Cabaletta Bio's Shares Issued stood at $4.3 million in 2021, then jumped by 41.25% to $6.0 million in 2022, then soared by 35.38% to $8.1 million in 2023, then jumped by 37.96% to $11.2 million in 2024, then advanced by 23.19% to $13.8 million in 2025.
- Business Quant data shows CABA's Shares Issued at $13.8 million in Q4 2025, $13.6 million in Q3 2025, and $7.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | 17.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.82 Mn |
| Jun 30, 2026 | 17.82 Mn |
| Dec 31, 2025 | 13.84 Mn |
| Dec 31, 2025 | 13.84 Mn |
| Sep 30, 2025 | 13.62 Mn |
| Sep 30, 2025 | 13.62 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Mar 31, 2025 | 6.45 Mn |
| Mar 31, 2025 | 6.45 Mn |
| Dec 31, 2024 | 11.23 Mn |
| Dec 31, 2024 | 11.23 Mn |
| Sep 30, 2024 | 5.26 Mn |
| Sep 30, 2024 | 5.26 Mn |
| Mar 31, 2024 | 4.46 Mn |
| Mar 31, 2024 | 4.46 Mn |
| Dec 31, 2023 | 8.14 Mn |
| Dec 31, 2023 | 8.14 Mn |
| Jun 30, 2023 | 3.60 Mn |
| Jun 30, 2023 | 3.60 Mn |